During the past decade, Frauenärzte am Schloss Borbeck conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Frauenärzte am Schloss Borbeck" are "Hot Flashes" (2 trials), "Vasomotor Symptoms Associated With Menopause" (1 trials) and "Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer" (1 trials). Many other conditions were trialed in "Frauenärzte am Schloss Borbeck" in a lesser frequency.

Most popular intervention types in "Frauenärzte am Schloss Borbeck" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Elinzanetant (BAY3427080)" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Frauenärzte am Schloss Borbeck" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Frauenärzte am Schloss Borbeck". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Frauenärzte am Schloss Borbeck, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Frauenärzte am Schloss Borbeck, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".